HMN 2025: What is the new time period to outline distinct occupational lung illness

In a review led by a multinational crew of specialists, researchers at National Jewish Health and their collaborators in Colorado, Illinois, Taiwan and Israel have launched a brand new time period to the medical lexicon: silicosarcoidosis. This novel designation describes instances where sufferers’ lung tissue displays overlapping options of each silicosis and sarcoidosis, two severe pulmonary ailments linked to occupational publicity to respirable crystalline silica (RCS) generally present in building, mining, and engineered stone fabrication.

Published within the American Journal of Industrial Medicine , the review represents the primary massive case sequence to definitively characterize silicosarcoidosis by way of lung biopsy. The findings carry main implications for illness recognition, medical therapy and occupational well being coverage.

“By coining the time period silicosarcoidosis, we hope to enhance identification and prognosis of this under-recognized {condition},” mentioned Jeremy Hua, MD, lead creator of the review and occupational pulmonologist at National Jewish Health. “Our work underscores the necessity for clinicians to think about occupational exposures when evaluating sufferers with sarcoidosis-like lung illness, particularly these in high-risk professions.”

The analysis analyzed 35 sufferers from the United States, Israel and Taiwan with confirmed sarcoidosis and long-term occupational publicity to RCS.

Lung tissue evaluation revealed that almost all of those sufferers exhibited traditional options of each silicosis and sarcoidosis.

Sarcoidosis, a systemic inflammatory {condition} of unknown origin, is more and more being linked to environmental and occupational exposures. However, publicity histories are not often sought throughout medical analysis. The study’s authors argue that the time period silicosarcoidosis will help bridge this hole by acknowledging silica publicity as a major and modifiable threat consider some sufferers with sarcoidosis.

A quantitative microscopy method developed by Dr. Hua’s analysis crew measured considerably elevated mud particle densities in lung tissue, confirming the overabundance of silica in comparison with wholesome controls.

The findings revealed the next diagnostic yield in bigger biopsy samples, suggesting that commonplace small lung tissue samples might miss key proof of silica publicity.

“This study brings much-needed readability to the overlap between two advanced lung ailments and reaffirms the important function of an publicity historical past in pulmonary prognosis,” mentioned Cecile Rose, MD, senior creator of the review and occupational pulmonologist at National Jewish Health.

“The introduction of ‘silicosarcoidosis’ marks a pivotal step in contemplating each therapy approaches and preventive methods, particularly in pulmonary medical practice.”